District Collectors have been asked to inform the surveillance team about the arrival of people coming from foreign countries in their respective districts, added Mohapatra.
The estimates suggest that Omicron cases have, on average, a 15-20 per cent reduced risk of any hospitalisation and an approximately 40-45 per cent reduced risk of a hospitalisation resulting in a stay of one or more nights.
Amidst the threat of a third wave of Covid-19 owing to the detection of new variant ‘Omicron’, Odisha Health Services Director, Bijay Mohapatra on Wednesday (Dec 22) explained the parameters to be followed to impose containment and restrictions.
With the detection of the two new positives in the States, the total tally of Omicron in Odisha has mounted to four.
The pill has also been approved for those at high risk for progression to severe Covid-19, including hospitalisation or death.
India recorded 7,495 new coronavirus infections taking the total tally of cases to 3,47,65,976, while the active cases increased to 78,291.
The second worst hit country in terms of cases is India (34,758,481 infections and 478,325 deaths), followed by Brazil (22,222,928 infections and 618,091 deaths).
The Deogarh district administration said that the positive students and staff have been isolated and all the Covid-19 protocols, sanitation and containment, are being followed at the school. If need arises, people will also be shifted to hospital.
If those vaccines had been distributed equitably, the 40 percent target could have been reached in every country by September, he added.
With rising scare of probable surge in the Corona infections driven by the newly discovered variant SARS-CoV-2 called Omicron, the Odisha government on Wednesday directed the district level authorities to enhance the daily Covid sample tests in the State to 70000.
Official sources said Modi will take stock of the pandemic situation across the country On Thursday.
The BMC has declared four flats (Flat No. G-151, G-132, G-142 and G-112) of Cosmopolis Apartment in Ward No 64 after the detection of the positive cases
A study published in the journal The Lancet on Monday showed that the protection offered by the Oxford-AstraZeneca Covid-19 vaccine, named Covishield in India, declines after three months of receiving two doses.
WHO Director General Tedros Adhanom Ghebreyesus said that 2022 must be the year we end the pandemic.
A separate study led by a joint team from the IITs Hyderabad and Kanpur is based on the Sutra model, which tracks the country's Covid-19 trajectory.
Copyright © 2024 - Odisha Television Limited All Rights Reserved.